Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
22.52
+0.56 (2.55%)
At close: Oct 24, 2025, 4:00 PM EDT
22.74
+0.22 (0.98%)
After-hours: Oct 24, 2025, 7:58 PM EDT
Schrödinger Revenue
Schrödinger had revenue of $54.76M in the quarter ending June 30, 2025, with 15.69% growth. This brings the company's revenue in the last twelve months to $237.92M, up 18.59% year-over-year. In the year 2024, Schrödinger had annual revenue of $207.54M, down -4.21%.
Revenue (ttm)
$237.92M
Revenue Growth
+18.59%
P/S Ratio
6.91
Revenue / Employee
$267,022
Employees
891
Market Cap
1.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 207.54M | -9.13M | -4.21% |
| Dec 31, 2023 | 216.67M | 35.71M | 19.73% |
| Dec 31, 2022 | 180.96M | 43.02M | 31.19% |
| Dec 31, 2021 | 137.93M | 29.84M | 27.60% |
| Dec 31, 2020 | 108.10M | 22.55M | 26.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SDGR News
- 4 days ago - Schrödinger to Announce Third Quarter 2025 Financial Results on November 5 - Business Wire
- 11 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Schrödinger, Inc. (SDGR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Business Wire
- 2 months ago - Schrödinger Announces Discontinuation of SGR-2921 Program - Business Wire
- 2 months ago - Schrödinger, Inc. (SDGR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Schrödinger Reports Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 - Business Wire